There is one clinical trial.

Clinical Trials

1 A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not responded at the end of the induction period in Study M14-234 Substudy 1, who have had loss of response during the maintenance period of Study M14-234 Substudy 3, or who have successfully completed Study M14-234 Substudy 3.

NCT03006068 Ulcerative Colitis (UC) Drug: Upadacitinib (ABT-494) Drug: Placebo

MeSH:Colitis Colitis, Ulcerative Ulcer

HPO:Colitis Ulcerative colitis

Related HPO nodes (Using clinical trials)